DGCI Approves For Phase III Trial Of Bharat Biotech Intranasal Vaccine As Booster
New Delhi: The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted "in principle" ...
Tag: Phase III booster dose
